Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Alzheimer’s disease

December 7, 2021 CD as API / CD derivatives / Pharma applications

Cyclo Therapeutics Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through

Continue reading

November 18, 2021 CD as API / CD derivatives / Pharma applications

Cyclo Therapeutics Submits IND Application to U.S. FDA to Advance Trappsol® Cyclo™ in Phase 2 Study for Treatment of Alzheimer’s Disease

Cyclo Therapeutics, Inc., a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and

Continue reading

December 10, 2020 CD as API / Events / Pharma applications

Cyclo Therapeutics Announces Pricing of $12.5 Million Public Offering

Transaction Includes Uplisting to Nasdaq and Reverse Stock Split Cyclo Therapeutics, Inc., a clinical stage biotechnology company developing a cyclodextrin

Continue reading

June 21, 2020 CD as API / CD derivatives / Pharma applications

Cyclo Therapeutics Reports on Eighteen Month Expanded Access Program in Single Alzheimer’s Patient

Cyclo Therapeutics, Inc., a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C

Continue reading

December 2, 2019 CD as API / Drug delivery / Pharma applications

International Conference on Alzheimer’s Disease & Dementia

International Conference on Alzheimer’s Disease & Dementia is scheduled Hilton  Rome Airport ,Rome, Italy from July 20 – 22, 2020. This International Conference

Continue reading

November 20, 2019 CD as API / CD derivatives / Pharma applications

Underdog Launches With $4M to Target “Toxic” Form of Cholesterol

Underdog Pharmaceuticals has launched with nearly $4 million in seed funding to develop treatments for atherosclerosis, a progressive condition in

Continue reading

Recent Posts

  • Special issue: Recent Insights in Chemistry and Technology of Cyclodextrins
  • Special issue: Cyclodextrins as building blocks for new materials
  • Matthieu SOLLOGOUB at ICS 20
  • CicloTech®, a new platform to improve trans-ungual drug release
  • Prof. Kohzo Ito at ICS 20

Tags

antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis Trappsol wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (27)
  • CD as API (177)
  • CD derivatives (229)
  • Cosmetics and toilettry (18)
  • Drug delivery (347)
  • E-ducation (49)
  • Environmental (62)
  • Events (149)
  • Food (100)
  • Gene delivery (8)
  • In Hungarian (4)
  • Life sciences (8)
  • Non-pharma applications (166)
  • Other industrial use (51)
  • Pharma applications (586)
  • Supramolecular systems (19)
  • Uncategorized (33)

Top Posts

  • Special issue: Recent Insights in Chemistry and Technology of Cyclodextrins
  • CicloTech®, a new platform to improve trans-ungual drug release
  • How air fresheners work?
  • Matthieu SOLLOGOUB at ICS 20
  • Special issue: Cyclodextrins as building blocks for new materials
  • Use of cyclodextrins as agrochemical delivery system
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • "NON-PHARMA USES OF CYCLODEXTRINS: Food; Nutraceuticals, Environmental and Other Industries, Agriculture” (webinar)
  • ICS2020 in Sicily concluded
  • Prof. Kohzo Ito at ICS 20

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 450 other subscribers

 

Loading Comments...